It has long been appreciated that African-American males have higher risk for diagnosis with prostate cancer, and higher risk for prostate cancer-specific mortality, than those of other ethnic origins living in the US. … READ MORE …
Filed under: Uncategorized | Tagged: African American, aggressiveness, decision-making, disparity, race, Treatment, white | 7 Comments »
It is relatively common knowledge — although never actually proven in a large, randomized, placebo-controlled trial — that statins like rosuvastatin (Crestor) and atorvastatin (Lipitor) may be helpful in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: African American, race, risk, statin, Treatment | 13 Comments »
Data from what appears to be one of the largest registry studies to date suggest that race does not increase risk for upstaging or upgrading in men who are eligible candidates for active surveillance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ethnicity, race, risk, upgrading, upstaging | 2 Comments »
It has long been suspected that “intrinsic biological differences” play a role in why different racial groups appear to have different risk levels for prostate cancer incidence and mortality. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biology, race, risk, RNA, splicing | Leave a comment »
An article in Oncology Nurse Advisor notes that “Black and white men prioritize certain treatment-related factors differently when considering prostate cancer treatment options.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: decision-making, priorities, race, risk, shared, Treatment | 7 Comments »
A newly published article in Prostate Cancer and Prostatic Diseases has (potentially) expanded our understanding of the role of saturated fats in men’s diets and consequent risk for diagnosis with aggressive forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: aggressive, diet, fat, race, risk, saturated, unsaturated | Leave a comment »
A new article in Urology (“the Gold Journal”) has again pointed out the race-related discrepancies between the application of definitive treatments for prostate cancer, particularly between Caucasian-American and African-American men. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: disparity, race, risk, Treatment | 1 Comment »
A newly published article in the British Medical Journal has shown that black males in England are twice as likely to be diagnosed with prostate cancer as white males, and are twice as likely to die of prostate cancer too. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: asian, black, England, ethnicity, incidence, mortality, race, white | 1 Comment »
In the past few years we have become used to seeing data from a range of studies suggesting that ongoing statin therapy is associated with both a lowered risk for diagnosis with prostate cancer and beneficial impact on the outcomes of treatment for prostate cancer once diagnosed. However, … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Diagnosis, ethnicity, race, risk, statin | Leave a comment »
The issue of treatment regret comes up regularly among men after first-line treatment for localized prostate cancer, but has been less commonly addressed among men with recurrent disease post-treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: black, race, regret, Treatment | 1 Comment »
A recent paper in Frontiers in Oncology offers us new information about the risk profiles of men initially diagnosed with clinical stage T1c disease in the USA in relatively recent years. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: age, Diagnosis, race, risk | Leave a comment »
A new study in the Journal of Clinical Oncology has suggested that African American men with very low-risk disease (according to the National Comprehensive Cancer Network or NCCN definition) are at higher risk for disease progression than comparable Caucasian patients if they follow active surveillance protocols. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, outcome, pathology, race, risk, surgery | Leave a comment »
A new article in Urology (“the Gold journal”) suggests that African American men diagnosed with low-risk forms of prostate cancer may need to meet more stringent criteria than Caucasian Americans if they are to be appropriately managed on active surveillance protocols. Why? Because they appear to be at higher risk for disease progression. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, Diagnosis, ethnicity, outcome, race, risk, surveillance | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 